Skip to main content
SpringerLink
Log in

Ungünstige Tumorbiologie - Kinderwunsch - jahrelange Nachsorge

Mammakarzinom bei jungen Frauen: Was Sie wissen sollten

  • Gynäkoonkologie
  • Fortbildung
  • Published:
Im Fokus Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Paluch-Shimon S et al. ESO-ESMO 3rd international consensus guidelines for breast cancer in young women (BCY3). Breast. 2017;35:203-17

    Article  Google Scholar 

  2. DeSantis C et al. Breast cancer statistics, 2013. CA Cancer J Clin. 2014;64(1):52-62

    Google Scholar 

  3. Leclere B et al. Trends in incidence of breast cancer among women under 40 in seven European countries: a GRELL cooperative study. Cancer Epidemiol. 2013;37(5):544-9

  4. Pronzato P et al. Biological characteristics and medical treatment of breast cancer in young women-a featured population: results from the NORA study. Int J Breast Cancer. 2011; https://doi.org/10.4061/2011/534256

    Article  Google Scholar 

  5. Banz-Jansen C et al. Characteristics and therapy of premenopausal patients with early-onset breast cancer in Germany. Arch Gynecol Obstet. 2012;286(2):489-93

    Article  Google Scholar 

  6. American Cancer Society. Breast Cancer Facts & Figures 2013-2014. Atlanta: American Cancer Society, Inc. 2013. https://www.cancer.org/research/cancer-facts-statistics/breast-cancer-facts-figures.html

  7. Couch FJ et al. Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer. JAMA Oncol. 2017;3(9):1190-6

    Article  Google Scholar 

  8. Kwon JS et al. Expanding the criteria for BRCA mutation testing in breast cancer survivors. J Clin Oncol. 2010;28(27):4214-20

    Article  Google Scholar 

  9. Interdisziplinäre S3-Leitlinie für die Früherkennung, Diagnostik, Therapie und Nachsorge des Mammakarzinoms. AWMF-Registernummer: 032-045OL 2018; Langversion 4.1

  10. Saha P et al. Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials. J Clin Oncol. 2017;35(27):3113-22

    Article  CAS  Google Scholar 

  11. Vila J et al. Overall survival according to type of surgery in young (</=40 years) early breast cancer patients: A systematic meta-analysis comparing breast-conserving surgery versus mastectomy. Breast. 2015;24(3):175-81

    Article  Google Scholar 

  12. Robson ME et al. OlympiAD final overall survival and tolerability results: Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer. Ann Oncol. 2019;30(4):558-66

    Article  Google Scholar 

  13. Schmid et al. Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer. N Engl J Med. 2018;379(22):2108-21

  14. Qi WX et al. Comparison between doublet agents versus single agent in metastatic breast cancer patients previously treated with an anthracycline and a taxane: a meta-analysis of four phase III trials. Breast. 2013;22:314-9

    Article  Google Scholar 

  15. Cardoso F et al. 4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4). Ann Oncol. 2018;29(8):1634-57

Download references

Author information

Authors and Affiliations

  1. Klinik u. Poliklinik f. Frauenheilk. u. Geburtshilfe, Marchioninistraße 15, 81377, München, Germany

    Maximiliane Burgmann

Authors
  1. Maximiliane Burgmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maximiliane Burgmann.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Burgmann, M. Mammakarzinom bei jungen Frauen: Was Sie wissen sollten. Im Fokus Onkologie 23, 25–28 (2020). https://doi.org/10.1007/s15015-019-0747-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15015-019-0747-5

Search

Navigation